Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Minimal-Risk, Multi-Center, Prospective, Clinical Trial to Evaluate the PrevisEA Device for Predicting Gastrointestinal Impairment

NCT04880473 is registered in ClinicalTrials.gov with Entac Medical Inc. as lead sponsor.

NCT NCT04880473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04880473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Minimal-Risk, Multi-Center, Prospective, Clinical Trial to Evaluate the PrevisEA Device for Predicting Gastrointestinal Impairment
Lead sponsor
Entac Medical Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
September 14, 2021
Completion date
December 1, 2024
Enrollment
400 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal complication